[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4339 followers Created: 2025-07-21 12:00:08 UTC $ITOS Merger of Equals: On July 18, 2025, iTeos Therapeutics, Inc. entered a merger agreement with Concentra Biosciences where shareholders will receive $XXXXXX per share in cash and contingent value rights related to future earnings; it will lead to iTeos becoming a subsidiary of Concentra. The merger is contingent upon Concentra acquiring over XX% of shares and having a minimum closing net cash of $XXX million. XXX engagements  **Related Topics** [stocks](/topic/stocks) [corporate finance](/topic/corporate-finance) [$itos](/topic/$itos) [Post Link](https://x.com/USCorpFilings/status/1947265331237622095)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SEC Filings Digest @USCorpFilings on x 4339 followers
Created: 2025-07-21 12:00:08 UTC
$ITOS Merger of Equals:
On July 18, 2025, iTeos Therapeutics, Inc. entered a merger agreement with Concentra Biosciences where shareholders will receive $XXXXXX per share in cash and contingent value rights related to future earnings; it will lead to iTeos becoming a subsidiary of Concentra. The merger is contingent upon Concentra acquiring over XX% of shares and having a minimum closing net cash of $XXX million.
XXX engagements
Related Topics stocks corporate finance $itos
/post/tweet::1947265331237622095